Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: the Pivotal Placebo-controlled Clinical Trial

By Insull W   Isaacsohn J   Kwiterovich P   Ma P   Brazg R   Dujovne C   Shan M   Shugrue-Crowley E   Ripa S   Tota R    

The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. : 47-68

Field House Publishing

Access to resources Recommend Favorite

Efficacy of Tamsulosin 0.4 mg/day in Relieving Double-J Stent-related Symptoms: a Randomized Controlled Study

By Navanimitkul N   Lojanapiwat B  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1436-1441

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab ( R))

By Stockis A.   De Bruyn S.   Deroubaix X.   Jeanbaptiste B.   Lebacq E.   Nollevaux F.   Poli G.   Acerbi D.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, Iss. 1, 2002-01 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite